课题基金 / 基金详情

ACTG 398: TRIAL OF AMPRENAVIR DUAL PROTEASE INHIBITOR REGIME IN COMBI

ACTG 398: TRIAL OF AMPRENAVIR DUAL PROTEASE INHIBITOR REGIME IN COMBI
ACTG 398:COMBI 中安普那韦双蛋白酶抑制剂方案的试验
批准号:
6263826
负责人:
Richard C. Reichman
金额:
$1.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Richard C. Reichman的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白酶抑制剂类药物对HIV感染者的长期临床结果很重要。鉴于在经历过病毒学失败的个体中实现病毒学抑制的公认困难,本研究的目的是a)提供最大有效的复杂方案,利用目前批准的蛋白酶抑制剂和蛋白酶抑制剂(Amprenavir),核苷(abacavir),核苷酸(adefovir)和非核苷(efavirenz)逆转录酶抑制剂类药物的实验药物的组合;B)研究含有双重蛋白酶抑制剂的方案中mprenavir的挽救潜力;C)确定如果对病毒学失败的定义适度宽松(如:d)确定在蛋白酶抑制剂失效的情况下,病毒学成功的严格定义(即达到血浆HIV-1 rna水平<每毫升200拷贝)是否现实,对于即将出现的治疗药物。
英文摘要
The protease inhibitor class of drugs is important for the long-term clinical outcome of HIV infected subjects. Given the recognized difficult in achieving virologic suppression in individuals who have been experienced virologic failure, this study has been designed with the purposes of a) providing maximally potent complex regimes utilixing combinations of currently approved protease inhibitors and experimental agents drawn from protease inhibitor (Amprenavir), nucleoside (abacavir), nucleotide (adefovir) and non-nucleoside (efavirenz) reverse transcriptase inhibitor classes of agents; b) investigating the salvage potential of mprenavir in dual protease inhibitor containing regimes; c) determining if the potential for salvage is greater if a moderately liberal definition of virologic failure (ie., 1,000 copies/ml plasms HIV rna) is employed and d) determining if a strict definition of virologic success in the setting of protease inhibitor failure (i.e, achieving plasma HIV-1 rna levels <200 copies per ml) is realistic with the therapeutic agents on the immediate horizon.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Units for HIV/AIDS Clinical Trials Networks
  • 批准号:
    7097857
  • 项目类别:
  • 资助金额:
    $256.85万
  • 财政年份:
    2007
  • 负责人:
    Richard C. Reichman
  • 依托单位:
ACTG A5142: COMPARISON STUDY OF THREE ANTIRETROVIRAL TREATMENT REGIMENS IN HIV
  • 批准号:
    7200093
  • 项目类别:
  • 资助金额:
    $8.8万
  • 财政年份:
    2005
  • 负责人:
    Richard C. Reichman
  • 依托单位:
A5186 TRIAL OF COMBINATION THERAPY ON TRIGLYCERIDE LEVELS IN SUBJECTS ON HAART T
  • 批准号:
    7200125
  • 项目类别:
  • 资助金额:
    $2.41万
  • 财政年份:
    2005
  • 负责人:
    Richard C. Reichman
  • 依托单位:
ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS W/ OPPORTUNISITIC INFECTIONS
  • 批准号:
    7200097
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2005
  • 负责人:
    Richard C. Reichman
  • 依托单位:
海外基金